PetMed Express, Inc. Appoints Carla Dodds as New Chief Marketing Officer
May 28 2024 - 8:00AM
PetMed Express, Inc., dba PetMeds and parent company of PetCareRx,
(Nasdaq: PETS) (the "Company") today announced the appointment of
Carla Dodds as Chief Marketing Officer (CMO). She brings extensive
experience in leadership roles encompassing marketing, strategy and
operations for major global companies including Walmart,
MasterCard, Curacao, Omnilife-Chivas Group, and Penske Media
Corporation. As CMO, Dodds will be responsible for leading PetMeds’
integrated marketing strategy including brand and content, digital
and lifecycle marketing, co-op media, customer acquisition and
retention, customer insights and market research, social media and
corporate communications.
“Carla is a dynamic and inspiring leader who brings a wealth of
experience in consumer behavior, integrated marketing solutions,
and modern, innovative campaigns focused on driving incrementality,
creating meaningful loyalty programs, and increasing brand equity,"
said Sandra Campos, President and CEO. "Her consumer-centric focus
aligns perfectly with our vision of prioritizing pets' needs in all
we do. She will be instrumental in our next phase of growth,
reinvigorating the PETS business."
“It’s an exciting time to join PetMeds as we harness the
combined power of our brands and unique platform to accelerate
growth,” said Carla Dodds, CMO. “I look forward to working
alongside such a talented team driven by our wellness companion
vision, centrally focused on our customers and their pets,
providing exceptional care at every interaction.”
About Carla Dodds
Ms. Dodds is a global executive with a passion for consumer
growth while driving impact, innovation, and transformation.
Throughout her extensive career in the U.S. and Latin America, she
has led and executed go-to-market business and marketing strategies
across several industries including Retail, CPG, Financial
Services, Private Equity, Telcom, MLM, and Energy. She is a servant
leader driven to both create and execute an organization’s vision,
while equally committing to people and the community.
Carla’s entrepreneurial spirit and desire to be at the forefront
of innovative solutions have allowed her opportunities to lead
diverse initiatives in product development and optimization across
multiple categories including, mobile, beverages, snacks, health
& wellness, beauty, apparel, sports, entertainment, and global
financial products. As an independent consultant and principal at
NovoMercatus LLC, she also served as interim/fractional CMO, CDO,
and COO for e-commerce, retail, consumer packaged goods, tech
companies, and various brands.
About PetMed Express, Inc.
Founded in 1996, PetMeds is a leader in pioneering the digital
pet pharmacy industry. As a national online retailer, PetMeds.com
and PetCareRx.com are top choices for delivering preventive and
chronic symptom prescriptions and OTC medications and products
through their thousands of veterinary partners and a loyal customer
base. Leveraging telehealth and insurance partnerships, they offer
unparalleled value and convenience to pet parents at every stage of
their pets' lives, whether dogs, cats, or horses. PetMeds and
PetCareRx provide a comprehensive range of medications, food
products, and essential supplies through their websites,
www.PetMeds.com and www.PetCareRx.com.
Forward Looking StatementThis press release may
contain “forward-looking statements”, within the meaning of Section
27A of the Securities Act of 1933, as amended, and Section 21E of
the Securities Exchange Act of 1934, as amended, that involve a
number of risks and uncertainties, including the Company’s ability
to meet the objectives included in its business plan. Important
factors that could cause results to differ materially from those
indicated by such forward-looking statements are set forth in the
“Risk Factors” and “Management’s Discussion and Analysis of
Financial Condition and Results of Operations” sections in the
Company’s Annual Report on Form 10-K/A for the year ended March 31,
2023. The Company’s future results may also be impacted by other
risk factors listed from time to time in the Company’s filings with
the Securities and Exchange Commission, including, but not limited
to, the Company's Annual Reports on Form 10-K, Quarterly Reports on
Form 10-Q and periodic filings on Form 8-K. You should not place
undue reliance on these forward-looking statements, which apply
only as of the date of this press release and should not be relied
upon as representing the Company’s views as of any subsequent date.
The Company explicitly disclaims any obligation to update any
forward-looking statements, other than as may be required by law.
If the Company does update one or more forward-looking statements,
no inference should be made that the Company will make additional
updates with respect to those or other forward-looking
statements.
Investor Contact:ICR, LLCJohn Mills(646)
277-1254
Reed Anderson(646) 277-1260
investor@petmeds.com
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/e7ade9e4-4790-4200-b77c-a84f1bdd6022
PetMed Express (NASDAQ:PETS)
Historical Stock Chart
From Sep 2024 to Oct 2024
PetMed Express (NASDAQ:PETS)
Historical Stock Chart
From Oct 2023 to Oct 2024